Ex vivo exposure to IL‐12 has been shown to protect tumor‐infiltrating murine CD8+ T cells from negative regulation by IFN‐γ via downregulation of IFNγR2 and PD‐1 expression in a mouse model of melanoma.29 This evidence concerns the gene IFNG and neoplasm.